Is Glenmark Pharmaceuticals Ltd halal to invest in?

As of July 2026, Glenmark Pharmaceuticals Ltd GLENMARK.NS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Glenmark Pharmaceuticals Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Glenmark Pharmaceuticals Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Glenmark Pharmaceuticals Ltd?

Muslim investors may consider investing in Glenmark Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Glenmark Pharmaceuticals Ltd classified as HALAL?

Musaffa determines the Shariah status of Glenmark Pharmaceuticals Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Glenmark Pharmaceuticals Ltd updated?

The Shariah compliance status of Glenmark Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Glenmark Pharmaceuticals Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Glenmark Pharmaceuticals Ltd?

You can check the latest Shariah compliance status of Glenmark Pharmaceuticals Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Glenmark Pharmaceuticals Ltd GLENMARK.NS

Last Updated: Jul 21, 12:00 AM·NSE

GLENMARK.NS Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Glenmark Pharmaceuticals Ltd is classified as halal.

HALAL

Report Source: 2026 Annual Report

Glenmark Pharmaceuticals Ltd. Stock Analysis GLENMARK.NS

India Health Care Mid Cap Report: 2026 Annual

Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. The firm hosts a diverse portfolio spanning branded, generics, and over-the-counter (OTC) segments. The firm is focused on the therapy areas of Respiratory, Dermatology and Oncology. The firm also has a regional/country-specific presence in other therapeutic areas like diabetes, cardiovascular and oral contraceptives. The Company’s offerings include complex injectables and biologics, oral solids, liquids, topical products, respiratory mdi1/dpi2/nasal sprays. The company is focused on developing products for markets such as India, Russia & CIS, Brazil, Asia and Africa. Its brands include RYALTRIS and SALMEX / ASTHMEX. RYALTRIS, the Company's first global branded specialty drug for treating symptoms of seasonal allergic rhinitis. The firm's subsidiaries include Glenmark Pharmaceuticals Inc., Ichnos Sciences Inc., and Glenmark Holding SA.

Key Statistics of Glenmark Pharmaceuticals Ltd (GLENMARK.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹2,221.10₹2,249.30

Today's Open

₹2,245.80

Volume

274.75K

P/E Ratio (TTM)

46.33

52 Week Range

₹1,792.60₹2,474.00

Market Cap

638.75B

Avg. Volume

564.42K

Dividend Yield

0.22%

Financial Metrics & Statements of Glenmark Pharmaceuticals Ltd (GLENMARK.NS)

Super Investors Invested in Glenmark Pharmaceuticals Ltd (GLENMARK.NS)

FAQ's for Glenmark Pharmaceuticals Ltd (GLENMARK.NS)

As of July 2026, Glenmark Pharmaceuticals Ltd GLENMARK.NS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Glenmark Pharmaceuticals Ltd using these criteria to determine its compliance status.
Muslim investors may consider investing in Glenmark Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Glenmark Pharmaceuticals Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Glenmark Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Glenmark Pharmaceuticals Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.